Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference19 articles.
1. Current uses and outcomes of hematopoietic stem cell transplantation (HCT);D’Souza,2016
2. Hematopoietic stem cell transplantation in Europe 2014: more than 40000 transplants annually;Passweg;Bone Marrow Transplant,2016
3. Hematopoietic cell transplant activity of Turkey in 2014 ongoing increase in transplant rates;Tekgündüz;Transfus Apher Sci,2016
4. Why are cancer drugs so expensive in the United States, and what are the solutions?;Kantarjian;Mayo Clin Proc,2015
5. Economics of hematopoietic cell transplantation;Khera;Blood,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122);Cancer Medicine;2023-03-23
2. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience;Transfusion and Apheresis Science;2021-08
3. Can biosimilar products be interchangeable? Pharmaceutical perspective in the implementation of biosimilars in oncology;Journal of Oncology Pharmacy Practice;2021-05-14
4. The comparison of effectiveness and safety between different biosimilars of G‐CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto‐PBSCT);Journal of Clinical Apheresis;2019-10-30
5. Medical and ethical considerations on hematopoietic stem cells mobilization for healthy donors;Transfusion Clinique et Biologique;2018-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3